Found: 38
Select item for more details and to access through your institution.
Prevalence of heart failure and the diagnostic value of MR‐proANP in outpatients with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 3, p. 736, doi. 10.1111/dom.13583
- By:
- Publication type:
- Article
Diabetes, Obesity and Metabolism.
- Published in:
- 2019
- By:
- Publication type:
- Abstract
PCSK9 inhibitors and diabetes: Translational biology to clinical practice.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 3, p. 451, doi. 10.1111/dom.13600
- By:
- Publication type:
- Article
Effect of glycaemic control on cardiovascular disease in individuals with type 2 diabetes with pre‐existing cardiovascular disease: A systematic review and meta‐analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 3, p. 732, doi. 10.1111/dom.13581
- By:
- Publication type:
- Article
Insulin glargine/lixisenatide fixed‐ratio combination improves glycaemic variability and control without increasing hypoglycaemia.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 3, p. 726, doi. 10.1111/dom.13580
- By:
- Publication type:
- Article
Reduction in albuminuria with dapagliflozin cannot be predicted by baseline clinical characteristics or changes in most other risk markers.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 3, p. 720, doi. 10.1111/dom.13579
- By:
- Publication type:
- Article
Hypoglycaemia as a function of HbA1c in type 2 diabetes: Insulin glargine 300 U/mL in a patient‐level pooled analysis of EDITION 1, 2 and 3.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 3, p. 715, doi. 10.1111/dom.13578
- By:
- Publication type:
- Article
What the diabetes data in the FOURIER trial fail to show.
- Published in:
- 2019
- By:
- Publication type:
- Letter to the Editor
CANadian CAnagliflozin REgistry: Effectiveness and safety of canagliflozin in the treatment of type 2 diabetes mellitus in Canadian clinical practice.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 3, p. 691, doi. 10.1111/dom.13573
- By:
- Publication type:
- Article
Low doses of dasiglucagon consistently increase plasma glucose levels from hypoglycaemia and euglycaemia in people with type 1 diabetes mellitus.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 3, p. 601, doi. 10.1111/dom.13562
- By:
- Publication type:
- Article
Ascorbic acid supplementation improves postprandial glycaemic control and blood pressure in individuals with type 2 diabetes: Findings of a randomized cross‐over trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 3, p. 674, doi. 10.1111/dom.13571
- By:
- Publication type:
- Article
Hypoglycaemia and gastric emptying.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 3, p. 491, doi. 10.1111/dom.13570
- By:
- Publication type:
- Article
Prevalence and progression of diabetic nephropathy in South Asian, white European and African Caribbean people with type 2 diabetes: A systematic review and meta‐analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 3, p. 658, doi. 10.1111/dom.13569
- By:
- Publication type:
- Article
Temporal changes in the incidence and predictors of severe hypoglycaemia in type 2 diabetes: The Fremantle Diabetes Study.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 3, p. 648, doi. 10.1111/dom.13568
- By:
- Publication type:
- Article
Follistatins in glucose regulation in healthy and obese individuals.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 3, p. 683, doi. 10.1111/dom.13572
- By:
- Publication type:
- Article
Teneligliptin versus sitagliptin in Korean patients with type 2 diabetes inadequately controlled with metformin and glimepiride: A randomized, double‐blind, non‐inferiority trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 3, p. 631, doi. 10.1111/dom.13566
- By:
- Publication type:
- Article
Day‐to‐day fasting self‐monitored blood glucose variability is associated with risk of hypoglycaemia in insulin‐treated patients with type 1 and type 2 diabetes: A post hoc analysis of the SWITCH Trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 3, p. 622, doi. 10.1111/dom.13565
- By:
- Publication type:
- Article
Evaluation of the long‐term cost‐effectiveness of once‐weekly semaglutide versus dulaglutide for treatment of type 2 diabetes mellitus in the UK.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 3, p. 611, doi. 10.1111/dom.13564
- By:
- Publication type:
- Article
Comparative effects of proximal and distal small intestinal administration of metformin on plasma glucose and glucagon‐like peptide‐1, and gastric emptying after oral glucose, in type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 3, p. 640, doi. 10.1111/dom.13567
- By:
- Publication type:
- Article
Gut microbiota and obesity: An opportunity to alter obesity through faecal microbiota transplant (FMT).
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 3, p. 479, doi. 10.1111/dom.13561
- By:
- Publication type:
- Article
Environmental effects of ambient temperature and relative humidity on insulin pharmacodynamics in adults with type 1 diabetes mellitus.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 3, p. 569, doi. 10.1111/dom.13555
- By:
- Publication type:
- Article
GlucoTab‐guided insulin therapy using insulin glargine U300 enables glycaemic control with low risk of hypoglycaemia in hospitalized patients with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 3, p. 584, doi. 10.1111/dom.13559
- By:
- Publication type:
- Article
Effect of switching from pioglitazone to the sodium glucose co‐transporter‐2 inhibitor dapagliflozin on body weight and metabolism‐related factors in patients with type 2 diabetes mellitus: An open‐label, prospective, randomized, parallel‐group comparison trial
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 3, p. 710, doi. 10.1111/dom.13557
- By:
- Publication type:
- Article
The relationships between markers of tubular injury and intrarenal haemodynamic function in adults with and without type 1 diabetes: Results from the Canadian Study of Longevity in Type 1 Diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 3, p. 575, doi. 10.1111/dom.13556
- By:
- Publication type:
- Article
FGF21 decreases food intake and body weight in obese Göttingen minipigs.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 3, p. 592, doi. 10.1111/dom.13560
- By:
- Publication type:
- Article
Cardiovascular safety of oral semaglutide in patients with type 2 diabetes: Rationale, design and patient baseline characteristics for the PIONEER 6 trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 3, p. 499, doi. 10.1111/dom.13553
- By:
- Publication type:
- Article
Personalized risk‐based screening for diabetic retinopathy: A multivariate approach versus the use of stratification rules.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 3, p. 560, doi. 10.1111/dom.13552
- By:
- Publication type:
- Article
Effectiveness of high‐intensity interval training combined with resistance training versus continuous moderate‐intensity training combined with resistance training in patients with type 2 diabetes: A one‐year randomized controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 3, p. 550, doi. 10.1111/dom.13551
- By:
- Publication type:
- Article
Association between diabetic eye disease and other complications of diabetes: Implications for care. A systematic review.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 3, p. 467, doi. 10.1111/dom.13550
- By:
- Publication type:
- Article
Effect of selenium supplementation on changes in HbA1c: Results from a multiple‐dose, randomized controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 3, p. 541, doi. 10.1111/dom.13549
- By:
- Publication type:
- Article
Effects of acute insulin‐induced hypoglycaemia on endothelial microparticles in adults with and without type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 3, p. 533, doi. 10.1111/dom.13548
- By:
- Publication type:
- Article
Health‐related quality of life in people with type 2 diabetes participating in the LEADER trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 3, p. 525, doi. 10.1111/dom.13547
- By:
- Publication type:
- Article
Pioglitazone prevents the increase in plasma ketone concentration associated with dapagliflozin in insulin‐treated T2DM patients: Results from the Qatar Study.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 3, p. 705, doi. 10.1111/dom.13546
- By:
- Publication type:
- Article
Exenatide corrects postprandial hyperglycaemia in young people with cystic fibrosis and impaired glucose tolerance: A randomized crossover trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 3, p. 700, doi. 10.1111/dom.13544
- By:
- Publication type:
- Article
Mineralocorticoid antagonism enhances brown adipose tissue function in humans: A randomized placebo‐controlled cross‐over study.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 3, p. 509, doi. 10.1111/dom.13539
- By:
- Publication type:
- Article
Worsening of diabetic retinopathy with rapid improvement in systemic glucose control: A review.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 3, p. 454, doi. 10.1111/dom.13538
- By:
- Publication type:
- Article
Diabetes, Obesity and Metabolism.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 3, p. 449, doi. 10.1111/dom.13427
- Publication type:
- Article
Effect of liraglutide on ambulatory blood pressure in patients with hypertension and type 2 diabetes: A randomized, double‐blind, placebo‐controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 3, p. 517, doi. 10.1111/dom.13541
- By:
- Publication type:
- Article